The association between FGF23 and inflammation, together with the activation of FGF receptor 4 on cardiac myocytes that promote left ventricular hypertrophy and intramyocardial fibrosis responsible for cardiovascular events in CKD [79], represent an additional novel mechanism of mortality linked to CKD. This evidence concerns the gene FGF23 and chronic kidney disease.